Aesthetic Injectables Devices Pipeline Product Landscape Report 2021 –

Aesthetic Injectables Devices Pipeline Product Landscape Report 2021 –

Aesthetic Injectables Devices Pipeline Product Landscape Report 2021 –

DUBLIN–(BUSINESS WIRE)–The “Aesthetic Injectables – Medical Devices Pipeline Product Landscape, 2021” report has been added to’s offering.

“Aesthetic Injectables – Medical Devices Pipeline Product Landscape, 2021” provides comprehensive information about the Aesthetic Injectables pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Aesthetic injectables refer to gel-like substances that are injected beneath the skin to restore a more youthful appearance. This is achieved by increasing the volume of sunken cheeks or temples, reducing lines around nose and mouth (marionette lines and smile lines), plumping up lips and enhancing facial contour.


  • Extensive coverage of the Aesthetic Injectables under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Aesthetic Injectables and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Aesthetic Injectables under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Key Topics Covered:

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Aesthetic Injectables Overview

3 Products under Development

3.1 Pipeline Products by Stage of Development

3.2 Pipeline Products by Segment

3.3 Pipeline Products by Territory

3.4 Pipeline Products by Regulatory Path

3.5 Pipeline Products by Estimated Approval Date

3.6 Ongoing Clinical Trials

4 Aesthetic Injectables – Pipeline Products under Development by Companies

4.1 Aesthetic Injectables Companies – Pipeline Products by Stage of Development

4.2 Aesthetic Injectables – Pipeline Products by Stage of Development

5 Aesthetic Injectables Companies and Product Overview

5.1 Advanced Aesthetic Technologies Inc Company Overview

5.2 Aeon Astron Corporation Company Overview

5.3 Aesthetic Medical Device Company Overview

5.4 Allergan Aesthetics Company Overview

5.5 Almirall Ltd Company Overview

5.6 Bioxis Pharmaceuticals Company Overview

5.7 BMG Pharma SpA Company Overview

5.8 Bmi Korea Co Ltd Company Overview

5.9 CellPraxis Company Overview

5.10 Celltrix AB Company Overview

5.11 Collplant Biotechnologies Ltd Company Overview

5.12 EternoGen Aesthetics LLC Company Overview

5.13 Fillmed Laboratoires Company Overview

5.14 Genzyme Corp Company Overview

5.15 Hallura Ltd Company Overview

5.16 Histogen Inc Company Overview

5.17 Hugel Inc Company Overview

5.18 Innovia LLC Company Overview

5.19 Juvenis Ltd Company Overview

5.20 Khorionyx SA Company Overview

5.21 LG Chem Ltd Company Overview

5.22 LifeSprout Inc Company Overview

5.23 Medytox Inc Company Overview

5.24 Mesoestetic Pharma Group SL Company Overview

5.25 Moma Therapeutics Inc Company Overview

5.26 N8 Medical LLC Company Overview

5.27 Oligo Medic Inc Company Overview

5.28 PB&B SA Company Overview

5.29 PetVivo Holdings Inc Company Overview

5.30 Q-Med AB Company Overview

5.31 Samyang Biopharmaceuticals Corp Company Overview

5.32 Sebana Medical Ltd Company Overview

5.33 Shanghai Haohai Biological Technology Co Ltd Company Overview

5.34 Shin Poong Pharm Co Ltd Company Overview

5.35 Silk Medical Aesthetics Inc Company Overview

5.36 Sinclair Pharma Ltd Company Overview

5.37 Sofregen Medical Inc Company Overview

5.38 SunMax Biotechnology Co Ltd Company Overview

5.39 TEI Biosciences Inc Company Overview

5.40 Tempo Therapeutics Inc Company Overview

5.41 Teoxane SA Company Overview

5.42 Tissueform Inc Company Overview

5.43 University of California Santa Barbara Company Overview

For more information about this report visit


Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900